Navigation Links
Avandia Raises Heart Risk But Should Stay on Market, FDA Panel Finds
Date:7/15/2010

lex ways than one might have imagined. The panel did the best they could with data that weren't completely conclusive, that suggested an increased risk but didn't make it clear how much that increased risk was," he said.

And he explained, "The majority of the panel didn't feel the increased risk was enough to summarily remove a drug that hundreds of thousands of people are taking successfully."

A second heart expert agreed.

"I didn't think that the evidence was yet compelling enough to withdraw the product from the market," said Dr. Kirk Garratt, clinical director of interventional cardiovascular research at Lenox Hill Hospital in New York City. "It sounds like they're going to add some new warnings regarding the risk, and that seems like an appropriate step."

And such a step will likely decrease the use of Avandia, anyway, Garratt added. "Use went down pretty sharply after criticism started to fly and the presence of new boxed warnings will further depress the prevalence of this product in the marketplace," he said.

But Garratt also said he didn't think the experts' votes would end the controversy over Avandia.

"There is so much dissent within the FDA about the appropriate action to take with this drug that I can't imagine this will be the final world," he said. "Also, we've got an alternative product [Actos] that seems to be essentially as effective at controlling diabetes but hasn't been linked to the cardiovascular risks."

In a statement released after the vote, Dr. Ellen Strahlman, chief medical officer at GlaxoSmithKline, which makes Avandia, said, "Following today's recommendations, we will, of course, continue to work with the FDA in the best interest of diabetes patients ... Patients taking Avandia should speak with their physician about their treatment and any questions they may have regarding the safety of the medicine."

The FDA committee had been meeting intensively since early Tuesday morning, hearing di
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3 4

Related medicine news :

1. FDA Panel Seems Skeptical Over Key Avandia Data
2. FDA Panel Appears Skeptical Over Key Avandia Data
3. Avandia Heart Risks Buried by Drug Company: Report
4. FDA Reviewer Questions Results of Key Avandia Trial
5. Latest Study on Diabetes Drug Avandia Finds No Heart Risks
6. Diabetes Drug Avandia Ups Heart Risk, Reviews Conclude
7. Maher Law Firm Warns Avandia Users - NY Times Reports - FDA Recommends Recall of Avandia
8. FDA: No Decision on Whether to Pull Diabetes Drug Avandia Off the Market
9. FDA Says It Hasnt Decided Whether to Pull Diabetes Drug Avandia Off the Market
10. Remove Diabetes Drug Avandia From Market: FDA Documents
11. Remove Diabetes Drug Avandia From Market: FDA Reports
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Avandia Raises Heart Risk But Should Stay on Market, FDA Panel Finds
(Date:8/3/2015)... ... August 03, 2015 , ... BESLER Consulting today announced ... Awards. , The MarketingProfs Bright Bulb B2B Awards celebrate the best marketing, communications, ... the launch of their Readmissions Analytics product was selected as one of four ...
(Date:8/3/2015)... (PRWEB) , ... August 03, 2015 , ... ... technologies and development solutions for drugs, biologics and consumer health products, today welcomed ... accepted for review OPKO’s New Drug Application for a new treatment for chronic ...
(Date:8/3/2015)... , ... August 03, 2015 , ... The art of ... Learning from her grandmother’s side at a young age, Nasreen Zereshki was extremely eager ... decided to share her cookbook Recipes from My Persian Kitchen with the world. , ...
(Date:8/3/2015)... ... 2015 , ... The U.S. Food and Drug Administration (FDA) recently approved a ... acid, which occurs naturally in the body and helps absorb and breakdown fat cells. ... the body. These are invasive procedures and very expensive for most people. Now with ...
(Date:8/3/2015)... (PRWEB) , ... August 03, 2015 , ... Dignity Health ... Health Arizona General Hospital Emergency Room – Gilbert, opening in August. The new ... this year in the West Valley. , “Dr. Baldwin is an excellent leader ...
Breaking Medicine News(10 mins):Health News:Catalent’s OptiShell™ Technology is Delivery Platform for OPKO Health’s New Chronic Kidney Disease Treatment 2Health News:Catalent’s OptiShell™ Technology is Delivery Platform for OPKO Health’s New Chronic Kidney Disease Treatment 3Health News:Persian Cuisine: Colorful and Extremely Healthy 2Health News:Dr. Ava Shamban to Offer the New Double Chin Treatment Kybella 2Health News:Dr. Ava Shamban to Offer the New Double Chin Treatment Kybella 3Health News:Dignity Health Names Dr. Norris A. Baldwin, Jr. Facility Medical Director of New Freestanding Emergency Room 2Health News:Dignity Health Names Dr. Norris A. Baldwin, Jr. Facility Medical Director of New Freestanding Emergency Room 3
... 8 Medivation, Inc.,(Nasdaq: MDVN ) today announced ... at the 27th Annual J.P. Morgan Healthcare,Conference on Wednesday, January ... Hotel in San Francisco. , Dr. ... programs for Dimebon for Alzheimer,s and Huntington,s diseases and,MDV3100 for ...
... announced today that Erik D. Olson has been named ... & Human Services Policy program. Olson, who was formerly ... Committee on Environment and Public Works, brings nearly 25 ... to Pew. "We are excited to be joined by ...
... be used when assessing traditional risk factors, experts say , , ... or "biomarkers" -- of inflammation may provide useful information when ... says. , "If you are very high or very low ... study lead author Dr. Vijay Nambi, a cardiologist at the ...
... Christine Siu and Jason Brown, Ph.D. Promoted to Vice ... Thomas, McNerney & Partners, a health care venture capital ... companies, today announced the promotion of three members of ... to Principal. Christine Siu and Jason Brown have ...
... ) announces the following Webcast: , What: Heska Corporation ... Year-End 2008 Earnings Conference Call on the Web, ... Where: www.heska.com (click on the Q4 and Year-End 2008 Earnings, ... of this website)., How: Live over the Internet ...
... 8 A proposal by the State of Indiana ... has prompted the 125,000-member American Legion Department of Indiana ... in order to organize and coordinate its members, nearly ... more than $50,000 in direct and in-kind support to ...
Cached Medicine News:Health News:Medivation Announces Participation in 27th Annual J.P. Morgan Healthcare Conference 2Health News:Veteran Environmental Health Expert Erik D. Olson to Join Pew 2Health News:Inflammation Markers May Help Predict Stroke Risk 2Health News:Inflammation Markers May Help Predict Stroke Risk 3Health News:Thomas, McNerney & Partners Promotes Three Members of Its Investment Team 2Health News:Webcast Alert: Heska Announces Fourth Quarter and Year-End 2008 Earnings Conference Call Webcast 2
(Date:8/3/2015)... NEWPORT NEWS, Va. , Aug. 3, 2015 ... will be joining Orthopaedic & Spine Center ... help them to manage their chronic pain through ... Dr. Robinson is a Fellowship-trained, certified medical ... and pain medicine. His vast experience ranges from ...
(Date:8/3/2015)... SINGAPORE , Aug. 3, 2015 ... Bloomberg: BIG SP; Reuters: BIOS.SI; SGX: B20), a ... today announced financial results for its first fiscal ... Quarter Highlights and Recent Developments: ... progress in improving its cost structure, driven by ...
(Date:8/3/2015)... , Aug. 3, 2015 Merrimack Pharmaceuticals, Inc. (Nasdaq: ... host its Second Quarter 2015 Investor Conference Call and ... The call will cover an update on ... quarter 2015 financials. A press release detailing the information ... the afternoon of Monday, August 10. Investors and the ...
Breaking Medicine Technology:Orthopaedic & Spine Center Introduces New Pain Psychologist 2Biosensors Reports Financial Results for the First Quarter of Fiscal Year 2016 2Biosensors Reports Financial Results for the First Quarter of Fiscal Year 2016 3Biosensors Reports Financial Results for the First Quarter of Fiscal Year 2016 4Biosensors Reports Financial Results for the First Quarter of Fiscal Year 2016 5Biosensors Reports Financial Results for the First Quarter of Fiscal Year 2016 6Merrimack Pharmaceuticals Announces Timing of Second Quarter 2015 Investor Conference Call 2
... BELGRADE, Mont., July 26, 2011 Bacterin ... a leader in the development of revolutionary bone graft material ... call on Thursday, August 11, at 4:30 p.m. Eastern time ... 2011. Financial results will be issued in a press release ...
... America, Inc. today announced plans to debut expanded software ... EasyCell® assistant Automated Cell Imaging Analyzer during ... Conference and Clinical Lab Expo July 24 - 28 ... hematology portfolio can be seen at Sysmex,s exhibit booth, ...
Cached Medicine Technology:Bacterin Sets Second Quarter 2011 Conference Call for Thursday, August 11, 2011 at 4:30 p.m. ET 2Sysmex America to Debut Expanded Software Products for Middleware and Cell Image Analysis at AACC 2011 2
For the quantitative determination of Iron and IBC in serum. Colorimetric method utilizing ferrozine. Endpoint procedure measured at 560 nm. Linearity: 500 ug/dl....
HDL Cholesterol (PEG) Precip. Reagent + 5 ml of 50 mg/dl cholesterol std....
Intended for the quantitative in vitro enzymatic determination of JDL-Cholesterol in human serum or plasma. Two point reaction. Wavelength: 600 nm. Linearity: 1 to 150 mg/dL (0.03 mmol/L to 3.89 mmol...
... Intended for the quantitative ... plasma. Two vials, dry ... alphaketoglutarate. Uses NADPH to ... plasma compounds. Reaction: Enzymatic, ...
Medicine Products: